Published in Proc Natl Acad Sci U S A on July 01, 1986
Regulated tissue-specific expression of antagonistic pre-mRNA splicing factors. RNA (1998) 4.05
Adenovirus virus-associated RNA and translation control. J Virol (1991) 3.77
Effects of mutations in stem and loop regions on the structure and function of adenovirus VA RNAI. EMBO J (1988) 1.58
A mechanism by which adenovirus virus-associated RNAI controls translation in a transient expression assay. Mol Cell Biol (1987) 1.53
Sequences involved in the control of adenovirus L1 alternative RNA splicing. Nucleic Acids Res (1991) 1.51
The adenovirus E4-ORF4 splicing enhancer protein interacts with a subset of phosphorylated SR proteins. EMBO J (2001) 1.36
Regulation of early adenovirus gene expression. Microbiol Rev (1987) 1.34
Functional dissection of adenovirus VAI RNA. J Virol (1989) 1.26
Adenovirus E4-dependent activation of the early E2 promoter is insufficient to promote the early-to-late-phase transition. J Virol (1991) 1.24
Adenovirus VAI-RNA regulates gene expression by controlling stability of ribosome-bound RNAs. EMBO J (1989) 1.14
Overexpression of essential splicing factor ASF/SF2 blocks the temporal shift in adenovirus pre-mRNA splicing and reduces virus progeny formation. J Virol (2000) 1.00
Cis requirements for alternative splicing of the cardiac troponin T pre-mRNA. Nucleic Acids Res (1988) 0.94
Regulation of adenovirus alternative RNA splicing at the level of commitment complex formation. Nucleic Acids Res (1994) 0.89
Characterization of a low-molecular-weight virus-associated (VA) RNA encoded by simian adenovirus type 7 which functionally can substitute for adenovirus type 5 VA RNAI. J Virol (1986) 0.88
The adenovirus VA RNA-derived miRNAs are not essential for lytic virus growth in tissue culture cells. Nucleic Acids Res (2013) 0.87
Enhanced splicing of nonconsensus 3' splice sites late during adenovirus infection. J Virol (1995) 0.85
Evidence for a HeLa cell splicing activity that is necessary for activation of a regulated adenovirus 3' splice site. Nucleic Acids Res (1992) 0.82
Expression of functionally active human antithrombin III. Proc Natl Acad Sci U S A (1987) 0.78
Biochemical transfer of single-copy eucaryotic genes using total cellular DNA as donor. Cell (1978) 19.44
Complex splicing patterns of RNAs from the early regions of adenovirus-2. J Mol Biol (1979) 7.53
Adenovirus VAI RNA is required for efficient translation of viral mRNAs at late times after infection. Cell (1982) 5.80
The 3' splice site of pre-messenger RNA is recognized by a small nuclear ribonucleoprotein. Science (1985) 4.56
Regulation of adenovirus-2 gene expression at the level of transcriptional termination and RNA processing. Nature (1981) 4.46
Structure of genes for virus-associated RNAI and RNAII of adenovirus type 2. Proc Natl Acad Sci U S A (1980) 3.45
A mechanism for the control of protein synthesis by adenovirus VA RNAI. Cell (1986) 3.43
Inhibition of HeLa cell protein synthesis during adenovirus infection. Restriction of cellular messenger RNA sequences to the nucleus. J Mol Biol (1979) 3.32
Adenovirus VAI RNA prevents phosphorylation of the eukaryotic initiation factor 2 alpha subunit subsequent to infection. Proc Natl Acad Sci U S A (1985) 3.09
RNA of low molecular weight in KB cells infected with adenovirus type 2. J Mol Biol (1966) 3.09
Adenovirus assay by the fluorescent cell-counting procedure. Virology (1961) 2.84
Translational control by adenovirus: lack of virus-associated RNAI during adenovirus infection results in phosphorylation of initiation factor eIF-2 and inhibition of protein synthesis. Proc Natl Acad Sci U S A (1985) 2.53
Controls of RNA splicing and termination in the major late adenovirus transcription unit. Nature (1981) 2.49
Genes for VA-RNA in adenovirus 2. Cell (1975) 2.32
Binding of adenovirus VA RNA to mRNA: a possible role in splicing? Nature (1980) 2.28
Adenovirus VA RNAI: a positive regulator of mRNA translation. Mol Cell Biol (1984) 2.09
Control of messenger RNA concentration by differential cytoplasmic half-life. Adenovirus messenger RNAs from transcription units 1A and 1B. J Mol Biol (1981) 1.85
Control of adenovirus E1B mRNA synthesis by a shift in the activities of RNA splice sites. Mol Cell Biol (1984) 1.31
Partial block to transcription of human adenovirus type 2 late genes in abortively infected monkey cells. J Virol (1985) 1.15
Ultraviolet transcriptional unit mapping for the late genes in adenovirus type 2. Virology (1978) 0.83
Structure of two spliced mRNAs from the transforming region of human subgroup C adenoviruses. Nature (1979) 6.60
The gene for polypeptide IX of adenovirus type 2 and its unspliced messenger RNA. Cell (1980) 5.80
Randomized comparison between chemotherapy plus best supportive care with best supportive care in advanced gastric cancer. Ann Oncol (1997) 4.69
Sexually transmitted infection as a cause of anal cancer. N Engl J Med (1997) 4.05
Chemotherapy improves survival and quality of life in advanced pancreatic and biliary cancer. Ann Oncol (1996) 4.00
Structure of genes for virus-associated RNAI and RNAII of adenovirus type 2. Proc Natl Acad Sci U S A (1980) 3.45
Inhibition by SR proteins of splicing of a regulated adenovirus pre-mRNA. Nature (1996) 3.12
Adenovirus 2 early region 1A stimulates expression of both viral and cellular genes. EMBO J (1984) 3.03
Targeting of adenovirus E1A and E4-ORF3 proteins to nuclear matrix-associated PML bodies. J Cell Biol (1995) 2.93
Crystal structure of the NG domain from the signal-recognition particle receptor FtsY. Nature (1997) 2.51
Controls of RNA splicing and termination in the major late adenovirus transcription unit. Nature (1981) 2.49
Regulation of adenovirus alternative RNA splicing by dephosphorylation of SR proteins. Nature (1998) 2.26
Adenovirus VA RNAI: a positive regulator of mRNA translation. Mol Cell Biol (1984) 2.09
Adenovirus early gene products may control viral mRNA accumulation and translation in vivo. Cell (1981) 1.93
Splicing of adenovirus 2 early region 1A mRNAs is non-sequential. J Mol Biol (1983) 1.82
Adenovirus VA RNAI mediates a translational stimulation which is not restricted to the viral mRNAs. EMBO J (1985) 1.80
Sequence analysis of adenovirus DNA: complete nucleotide sequence of the spliced 5' noncoding region of adenovirus 2 hexon messenger RNA. Cell (1979) 1.73
An automated flinch detecting system for use in the formalin nociceptive bioassay. J Appl Physiol (1985) (2001) 1.68
Sequence analysis of adenovirus DNA. I. Nucleotide sequence at the carboxy-terminal end of the gene for adenovirus type 2 hexon. Virology (1978) 1.66
The splicing factor-associated protein, p32, regulates RNA splicing by inhibiting ASF/SF2 RNA binding and phosphorylation. EMBO J (1999) 1.63
Sensitive periods for glucocorticoids' regulation of Na+,K(+)-ATPase mRNA in the developing lung and kidney. Pediatr Res (1993) 1.62
Prevalence of nasal symptoms and their relation to self-reported asthma and chronic bronchitis/emphysema. Eur Respir J (2001) 1.61
Genetic identification of an endoproteinase encoded by the adenovirus genome. J Mol Biol (1983) 1.58
Sequence analysis of adenovirus DNA. IV. The genomic sequences encoding the common tripartite leader of late adenovirus messenger RNA. J Mol Biol (1979) 1.55
The carboxy-terminal region of adenovirus E1A activates transcription through targeting of a C-terminal binding protein-histone deacetylase complex. FEBS Lett (1998) 1.55
Human adenovirus encodes two proteins which have opposite effects on accumulation of alternatively spliced mRNAs. Mol Cell Biol (1994) 1.54
A mechanism by which adenovirus virus-associated RNAI controls translation in a transient expression assay. Mol Cell Biol (1987) 1.53
Plasma exudation as a first line respiratory mucosal defence. Clin Exp Allergy (1991) 1.52
Environmental tobacco smoke and lung cancer in nonsmokers: does time since exposure play a role? Epidemiology (1998) 1.51
Sequences involved in the control of adenovirus L1 alternative RNA splicing. Nucleic Acids Res (1991) 1.51
Gene and mRNA for precursor polypeptide VI from adenovirus type 2. J Virol (1981) 1.49
Adenovirus 3 fiber polypeptide gene: implications for the structure of the fiber protein. J Virol (1985) 1.47
A novel adenovirus-2 E1A mRNA encoding a protein with transcription activation properties. EMBO J (1987) 1.47
Nucleotide sequence at the junction between the coding region of the adenovirus 2 hexon messenger RNA and its leader sequence. Proc Natl Acad Sci U S A (1978) 1.45
DNA sequence analysis of the region encoding the terminal protein and the hypothetical N-gene product of adenovirus type 2. J Biol Chem (1982) 1.44
Dose-dependent effects of budesonide aqueous nasal spray on symptoms in a daily nasal allergen challenge model. Ann Allergy Asthma Immunol (2000) 1.42
The acute antihyperalgesic action of nonsteroidal, anti-inflammatory drugs and release of spinal prostaglandin E2 is mediated by the inhibition of constitutive spinal cyclooxygenase-2 (COX-2) but not COX-1. J Neurosci (2001) 1.41
Identification of sequences in Epstein-Barr virus DNA required for the expression of the second Epstein-Barr virus-determined nuclear antigen in COS-1 cells. J Gen Virol (1987) 1.40
Region E3 of human adenoviruses; differences between the oncogenic adenovirus-3 and the non-oncogenic adenovirus-2. Gene (1986) 1.39
The adenovirus E4-ORF4 splicing enhancer protein interacts with a subset of phosphorylated SR proteins. EMBO J (2001) 1.36
Final results of a randomised trial comparing 'Tomudex' (raltitrexed) with 5-fluorouracil plus leucovorin in advanced colorectal cancer. "Tomudex" Colorectal Cancer Study Group. Ann Oncol (1996) 1.33
The CtBP binding domain in the adenovirus E1A protein controls CR1-dependent transactivation. Nucleic Acids Res (1996) 1.33
Two adenovirus proteins with redundant activities in virus growth facilitates tripartite leader mRNA accumulation. Virology (1993) 1.33
The sequence of the 3' non-coding region of the hexon mRNA discloses a novel adenovirus gene. Nucleic Acids Res (1981) 1.31
Crystal structure of the ligand binding domain of the human nuclear receptor PPARgamma. J Biol Chem (1998) 1.30
Adenovirus-mediated overexpression of p15INK4B inhibits human glioma cell growth, induces replicative senescence, and inhibits telomerase activity similarly to p16INK4A. Cell Growth Differ (2000) 1.29
Residential radon exposure and lung cancer in Swedish women. Health Phys (1992) 1.27
Abnormalities by pulmonary regions studied with computer tomography following local or local-regional radiotherapy for breast cancer. Int J Radiat Oncol Biol Phys (1999) 1.25
Adenovirus E4 open reading frame 4 protein autoregulates E4 transcription by inhibiting E1A transactivation of the E4 promoter. J Virol (1996) 1.24
The use of the nose to study the inflammatory response of the respiratory tract. Thorax (1992) 1.22
Polyadenylic acid addition sites in the adenovirus type 2 major late transcription unit. J Virol (1983) 1.22
Beta cell proliferation and growth factors. J Mol Med (Berl) (1999) 1.20
Splicing of the adenovirus-2 E1A 13S mRNA requires a minimal intron length and specific intron signals. Nucleic Acids Res (1985) 1.19
A novel effect of adenovirus VA RNA1 on cytoplasmic mRNA abundance. Virology (1990) 1.17
Background factors in patients with schizoaffective disorder as compared with patients with diabetes and healthy individuals. Eur Arch Psychiatry Clin Neurosci (1996) 1.16
The gene for the adenovirus 2 hexon polypeptide. J Biol Chem (1984) 1.15
A U1 snRNA binding site improves the efficiency of in vitro pre-mRNA splicing. Nucleic Acids Res (1991) 1.13
Crystal structure of phosphoadenylyl sulphate (PAPS) reductase: a new family of adenine nucleotide alpha hydrolases. Structure (1997) 1.13
MGMT promoter hypermethylation correlates with a survival benefit from temozolomide in patients with recurrent anaplastic astrocytoma but not glioblastoma. Eur J Cancer (2008) 1.12
'Tomudex' (ZD1694): results of a randomised trial in advanced colorectal cancer demonstrate efficacy and reduced mucositis and leucopenia. The 'Tomudex' Colorectal Cancer Study Group. Eur J Cancer (1995) 1.12
Randomized trial of Lichtenstein versus Shouldice hernia repair in general surgical practice. Br J Surg (2002) 1.11
Neurogenin 3+ cells contribute to β-cell neogenesis and proliferation in injured adult mouse pancreas. Cell Death Dis (2013) 1.11
The social network of patients with schizoaffective disorder as compared to healthy individuals. Soc Sci Med (1995) 1.09
Control of adenovirus major late gene expression at multiple levels. J Mol Biol (1992) 1.08
Cisplatin induces the proapoptotic conformation of Bak in a deltaMEKK1-dependent manner. Mol Cell Biol (2001) 1.07
The adenovirus hexon protein. The primary structure of the polypeptide and its correlation with the hexon gene. J Biol Chem (1981) 1.07
Enhanced invasive properties of rat embryo fibroblasts transformed by adenovirus E1A mutants with deletions in the carboxy-terminal exon. Oncogene (1992) 1.06
Role of the branch site/3'-splice site region in adenovirus-2 E1A pre-mRNA alternative splicing: evidence for 5'- and 3'-splice site co-operation. Nucleic Acids Res (1989) 1.06
An adenovirus E1A transcriptional repressor domain functions as an activator when tethered to a promoter. Nucleic Acids Res (1994) 1.05
Effect of seasonal allergic rhinitis on airway mucosal absorption of chromium-51 labelled EDTA. Thorax (1993) 1.05
An improved nuclear extract preparation method. Gene Anal Tech (1989) 1.03
Genes encoding the core proteins of adenovirus type 2. J Biol Chem (1984) 1.03
Two novel adenovirus vector systems permitting regulated protein expression in gene transfer experiments. J Virol (1998) 1.02
Glucose kinase of Streptomyces coelicolor A3(2): large-scale purification and biochemical analysis. Antonie Van Leeuwenhoek (2000) 1.01
Various methods for testing nasal responses in vivo: a critical review. Acta Otolaryngol (1995) 1.01
Salvage abdominoperineal resection in anal epidermoid cancer. Br J Surg (2002) 1.00
Overexpression of essential splicing factor ASF/SF2 blocks the temporal shift in adenovirus pre-mRNA splicing and reduces virus progeny formation. J Virol (2000) 1.00
Airway permeability. Clin Exp Allergy (1995) 0.99
Functional knockout of the corepressor CtBP by the second exon of adenovirus E1a relieves repression of transcription. Exp Cell Res (2001) 0.98
The adenovirus-2 E1B-55K protein interacts with a mSin3A/histone deacetylase 1 complex. FEBS Lett (2000) 0.98
Biochemical and molecular actions of interleukin-1 on pancreatic beta-cells. Autoimmunity (1991) 0.98
Abundance of Na(+)-K(+)-ATPase mRNA is regulated by glucocorticoid hormones in infant rat kidneys. Am J Physiol (1991) 0.98
Technical prerequisites for in vivo microdialysis determination of interleukin-6 in human dermis. Br J Dermatol (2002) 0.98
Contribution of plasma-derived molecules to mucosal immune defence, disease and repair in the airways. Scand J Immunol (1998) 0.97
The carboxy-terminal exon of the adenovirus E1A protein is required for E4F-dependent transcription activation. EMBO J (1992) 0.97
Dietary factors and risk of lung cancer in never-smokers. Int J Cancer (1998) 0.97
Independent transformation activity by adenovirus-5 E1A-conserved regions 1 or 2 mutants. Virology (1991) 0.97
Plasma-derived proteins in airway defence, disease and repair of epithelial injury. Eur Respir J (1998) 0.97
Circulating eosinophil/basophil progenitors and nasal mucosal cytokines in seasonal allergic rhinitis. Allergy (1999) 0.96
Functional coexpression of serine protein kinase SRPK1 and its substrate ASF/SF2 in Escherichia coli. Nucleic Acids Res (2000) 0.96